The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

Among key components of drive is digital ‘thikri pehra’, installation of night-vision CCTV cameras and sound recording ...

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.

FDA inspections are essential to ensuring the safety and quality of products in the food, pharmaceutical, and medical device industries. One of the experienced professionals in this field is John ...

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

Fujirebio Diagnostics created the test to assess the ratio of two proteins in the blood. The rato is associated with amyloid ...

Boise police found explosive devices during what began as a drug investigation. BPD’s Bomb Squad was called out, and ...

The FDA has cleared first blood-based in vitro diagnostic tool for detecting Alzheimer’s disease. It is approved for use in ...